We are live on ! Find out more
RCMT icon

RCM Technologies

35 hedge funds and large institutions have $40.4M invested in RCM Technologies in 2016 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

52.62% more ownership

Funds ownership: 0%52.62% (+53%)

29% more capital invested

Capital invested by funds: $31.2M → $40.4M (+$9.18M)

29% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 7

13% more funds holding

Funds holding: 3135 (+4)

Holders
35
Holders Change
+4
Holders Change %
+12.9%
% of All Funds
0.88%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
7
Increased
9
Reduced
7
Closed
3
Calls
Puts
Net Calls
Net Calls Change

RCMT Hedge Fund Activity: Q4 2016 in Review

35 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in RCM Technologies (RCMT) for Q4 2016, worth a combined $40.4M — up 29% from $31.2M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new RCMT positions and 3 closed out — a net gain of 4 holders — while 9 added to existing stakes and 7 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.19M. The largest seller was Frontier Investment Management, exiting entirely with an estimated $6.5M sold.

  • 35 institutional investors held RCM Technologies (RCMT) as of Q4 2016, up from 31 in Q3 2016.
  • Funds reported $40.4M of RCM Technologies stock for Q4 2016, up 29% quarter-over-quarter.
  • 7 funds opened new RCM Technologies positions in Q4 2016 and 3 closed out, a net change of +4 holders.
  • The largest RCM Technologies buyer in Q4 2016 was Vanguard Group, an estimated $1.19M added.
  • The largest RCM Technologies seller in Q4 2016 was Frontier Investment Management, an estimated $6.5M sold.

Based on aggregated 13F filings for Q4 2016.